ANDREA REED: Open Payments
NPI 1225766629 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 28 payments from 8 companies in 2025. Trend: 2023 $265 · 2024 $670 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $215 |
| ABBVIE INC. | 3 | $169 |
| Boston Scientific Corporation | 8 | $166 |
| Janssen Scientific Affairs, LLC | 1 | $108 |
| Janssen Biotech, Inc. | 4 | $69 |
| QOL Medical, LLC | 1 | $41 |
| Madrigal Pharmaceuticals | 1 | $39 |
| GENZYME CORPORATION | 1 | $28 |
Products named: XIFAXAN, TREMFYA, General - Embolics, Sucraid, REZDIFFRA, SKYRIZI, DUPIXENT, CREON.
Industry payments across GA — which companies pay providers there.
